Authors:
HARDMAN TC
CROFT P
MORRISH Z
ANTOAWOAKYE K
LANT AF
Citation: Tc. Hardman et al., KINETIC CHARACTERISTICS OF THE ERYTHROCYTE SODIUM-LITHIUM COUNTERTRANSPORTER IN BLACK NORMOTENSIVE SUBJECTS COMPARED WITH 3 OTHER ETHNIC-GROUPS, Journal of human hypertension, 12(1), 1998, pp. 29-34
Authors:
NOORMOHAMED FH
YOULE MS
HIGGS CJ
MARTINMUNLEY S
GAZZARD BG
LANT AF
Citation: Fh. Noormohamed et al., PHARMACOKINETICS AND ABSOLUTE BIOAVAILABILITY OF ORAL FOSCARNET IN HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE PATIENTS, Antimicrobial agents and chemotherapy, 42(2), 1998, pp. 293-297
Citation: Tc. Hardman et al., CHARACTERIZATION OF THE ERYTHROCYTE SODIUM-LITHIUM COUNTERTRANSPORTER- LIMITATIONS AND ASSUMPTIONS OF TRADITIONAL AND KINETIC METHODOLOGIES, The Journal of membrane biology, 161(2), 1998, pp. 197-205
Citation: Ms. Youle et al., RENAL EXCRETION AND PHARMACOKINETICS OF FOSCARNET IN HIV-SEROPOSITIVEPATIENTS - EFFECT OF PROBENECID PRETREATMENT, British journal of clinical pharmacology, 43(1), 1997, pp. 112-115
Authors:
HARDMAN TC
WIERZBICKI AS
CROFT P
FEHER M
COX A
LANT AF
Citation: Tc. Hardman et al., ANGIOTENSIN-CONVERTING ENZYME (ACE) GENE POLYMORPHISM AND THE ERYTHROCYTE SODIUM-LITHIUM COUNTERTRANSPORTER (SLC) PHENOTYPE IN HYPERTENSION, Journal of human hypertension, 10(6), 1996, pp. 429-430
Authors:
HARDMAN TC
BARLOW R
DUBREY SW
CROFT P
LANT AF
Citation: Tc. Hardman et al., KINETIC CHARACTERISTICS OF THE ERYTHROCYTE SODIUM-LITHIUM COUNTERTRANSPORTER IN SUBJECTS WITH CORONARY-ARTERY DISEASE, American journal of hypertension, 9(2), 1996, pp. 184-187
Citation: Md. Feher et al., SHORT-TERM BLOOD-PRESSURE AND METABOLIC EFFECTS OF TIBOLONE IN POSTMENOPAUSAL WOMEN WITH NON-INSULIN-DEPENDENT DIABETES, British journal of obstetrics and gynaecology, 103(3), 1996, pp. 281-283
Citation: Tc. Hardman et al., ERYTHROCYTE SODIUM-LITHIUM COUNTERTRANSPORT ACTIVITY IN NONNEPHROPATHIC DIABETIC TWINS, Diabetes care, 19(1), 1996, pp. 32-38
Citation: Tc. Hardman et al., KINETIC-BEHAVIOR OF THE ERYTHROCYTE SODIUM-LITHIUM COUNTERTRANSPORTERIN NONNEPHROPATHIC DIABETIC TWINS, Metabolism, clinical and experimental, 45(10), 1996, pp. 1203-1207
Authors:
OSE L
SCOTT R
BRUSCO O
UGARTE AC
DESCAMPS O
HELLER F
PAQUOT N
SCHEEN A
BERTOLAMI MC
FORTI N
RICHTER W
SELMAIER A
ZIEGLASCH HJ
KLOER H
BADE R
WANNER C
KOESTER W
KRAEMERGUTH A
BILIANOU H
LEFKOS N
EFTHIMIADIS A
KASTELEIN J
VANDAM M
VANDEWIEL A
LINTOTT C
SUNDT E
ISTAD H
LOENNECHEN CW
UTNE E
HOLE T
SKARE S
URHEIM S
CAMPODINCO S
MORALES R
IZA A
ALVAREZ L
SY R
YEBES R
LEE CY
TAN A
QUEK S
VERMAK WJH
VORSTER HH
RAAL FJ
KELLER U
NOSEDA G
BONETTI T
CRAWFORD GM
BLOOMFIELD P
SUTHERLAND K
RYLANCE PB
BROOM J
BAKSI AK
LANT AF
HUGHES EA
Citation: L. Ose et al., DOUBLE-BLIND COMPARISON OF THE EFFICACY AND TOLERABILITY OF SIMVASTATIN AND FLUVASTATIN IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA, Clinical drug investigation, 10(3), 1995, pp. 127-138
Authors:
WIERZBICKI AS
NIMMO L
FEHER MD
COX A
FOXTON J
LANT AF
Citation: As. Wierzbicki et al., ASSOCIATION OF ANGIOTENSIN-CONVERTING ENZYME-DD GENOTYPE WITH HYPERTENSION IN DIABETES, Journal of human hypertension, 9(8), 1995, pp. 671-673
Authors:
HARDMAN TC
CROFT P
BARLOW R
WIERZBICKI AS
FEHER MD
LANT AF
Citation: Tc. Hardman et al., ETHNIC-ORIGIN AND HYPERTENSION-ASSOCIATED ALTERATIONS IN SODIUM-LITHIUM COUNTERTRANSPORT KINETICS, Journal of human hypertension, 9(8), 1995, pp. 687-689
Citation: Tc. Hardman et al., RELATION OF SODIUM-LITHIUM COUNTERTRANSPORT ACTIVITY TO MARKERS OF CARDIOVASCULAR RISK IN NORMOTENSIVE SUBJECTS, Journal of human hypertension, 9(7), 1995, pp. 589-596
Citation: Fh. Noormohamed et Af. Lant, RENAL HANDLING OF LITHIUM AND THE EFFECTS OF MANNITOL AND ARGININE-VASOPRESSIN IN MAN, Clinical science, 89(1), 1995, pp. 27-36
Citation: Fh. Noormohamed et Af. Lant, EFFECTS OF ARGININE-VASOPRESSIN ON RENAL HANDLING OF CALCIUM AND MAGNESIUM IN HEALTHY HYDRATED MAN, Journal of physiology, 489P, 1995, pp. 86-86
Citation: Md. Feher et al., FAT ARMS, OBESITY AND CHOICE OF BLOOD-PRESSURE CUFF SIZE IN DIABETIC-PATIENTS, British journal of clinical practice, 49(6), 1995, pp. 286-287
Citation: Md. Feher et al., LONG-TERM SAFETY OF STATIN-FIBRATE COMBINATION TREATMENT IN THE MANAGEMENT OF HYPERCHOLESTEROLEMIA IN PATIENTS WITH CORONARY-ARTERY DISEASE, British Heart Journal, 74(1), 1995, pp. 14-17
Authors:
HARDMAN TC
DUBREY SW
BARLOW R
FEHER MD
LANT AF
Citation: Tc. Hardman et al., LACK OF ACUTE EFFECTS OF A STANDARDIZED FAT MEAL OR EXERCISE ON ERYTHROCYTE SODIUM-LITHIUM COUNTERTRANSPORT ACTIVITY, Journal of human hypertension, 8(8), 1994, pp. 641-643
Authors:
RUTHERFORD PA
THOMAS TH
HARDMAN T
LANT AF
WILKINSON R
Citation: Pa. Rutherford et al., SODIUM-LITHIUM COUNTERTRANSPORT ACTIVITY IS NOT AFFECTED BY SHORT-TERM INSULIN EXPOSURE IN-VIVO OR IN A PHYSIOLOGICAL MEDIUM IN-VITRO, Metabolism, clinical and experimental, 42(9), 1993, pp. 1087-1089
Authors:
FEHER MD
WEBB JC
PATEL DD
LANT AF
MAYNE PD
KNIGHT BL
SOUTAR AK
Citation: Md. Feher et al., CHOLESTEROL-LOWERING DRUG-THERAPY IN A PATIENT WITH RECEPTOR-NEGATIVEHOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, Atherosclerosis, 103(2), 1993, pp. 171-180